TY - JOUR
T1 - Inhibition of Th2-mediated allergic airway inflammatory disease by CD137 costimulation
AU - Sun, Yonglian
AU - Blink, Sarah E.
AU - Liu, Wenhua
AU - Lee, Youjin
AU - Chen, Bohao
AU - Solway, Julian
AU - Weinstock, Joel
AU - Chen, Lieping
AU - Fu, Yang Xin
N1 - Copyright:
Copyright 2017 Elsevier B.V., All rights reserved.
PY - 2006/7/15
Y1 - 2006/7/15
N2 - The engagement of CD137 (4-1BB), an inducible T cell costimulatory receptor and member of the TNF receptor superfamily, by agonistic Abs can promote strong tumor and viral immunity mediated by CD8+ T cells and stimulate IFN-γ production. However, its role in Th2-mediated immune responses has not been well defined. To address this issue, we studied the function of CD137 engagement using an allergic airway disease model in which the mice were sensitized with inactivated Schistosoma mansoni eggs followed by S. mansoni egg Ag challenge directly in the airways and Th1/2 cytokine production was monitored. Interestingly, treatment of C57BL/6 mice with agonistic anti-CD137 (2A) during sensitization completely prevents allergic airway inflammation, as shown by a clear inhibition of T cell and eosinophil infiltration into the lung tissue and airways, accompanied by diminished Th2 cytokine production and reduced serum IgE levels, as well as a reduction of airway hyperresponsiveness. At various time points after immunization, restimulated splenocytes from 2A-treated mice displayed reduced proliferation and Th2 cylokine production. In accordance with this, agonistic Ab to CD137 can directly coinhibit Th2 responses in vitro although it costimulates Th1 responses. CD137-mediated suppression of Th2 response is independent of IFN-γ and T regulatory cells. Our study has identified a novel pathway to inhibit Th2 responses in a CD137-dependent fashion.
AB - The engagement of CD137 (4-1BB), an inducible T cell costimulatory receptor and member of the TNF receptor superfamily, by agonistic Abs can promote strong tumor and viral immunity mediated by CD8+ T cells and stimulate IFN-γ production. However, its role in Th2-mediated immune responses has not been well defined. To address this issue, we studied the function of CD137 engagement using an allergic airway disease model in which the mice were sensitized with inactivated Schistosoma mansoni eggs followed by S. mansoni egg Ag challenge directly in the airways and Th1/2 cytokine production was monitored. Interestingly, treatment of C57BL/6 mice with agonistic anti-CD137 (2A) during sensitization completely prevents allergic airway inflammation, as shown by a clear inhibition of T cell and eosinophil infiltration into the lung tissue and airways, accompanied by diminished Th2 cytokine production and reduced serum IgE levels, as well as a reduction of airway hyperresponsiveness. At various time points after immunization, restimulated splenocytes from 2A-treated mice displayed reduced proliferation and Th2 cylokine production. In accordance with this, agonistic Ab to CD137 can directly coinhibit Th2 responses in vitro although it costimulates Th1 responses. CD137-mediated suppression of Th2 response is independent of IFN-γ and T regulatory cells. Our study has identified a novel pathway to inhibit Th2 responses in a CD137-dependent fashion.
UR - http://www.scopus.com/inward/record.url?scp=33745842255&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33745842255&partnerID=8YFLogxK
U2 - 10.4049/jimmunol.177.2.814
DO - 10.4049/jimmunol.177.2.814
M3 - Article
C2 - 16818735
AN - SCOPUS:33745842255
SN - 0022-1767
VL - 177
SP - 814
EP - 821
JO - Journal of Immunology
JF - Journal of Immunology
IS - 2
ER -